comparemela.com

Latest Breaking News On - Brain targeting - Page 1 : comparemela.com

BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program

/PRNewswire/ BIORCHESTRA, a biotherapeutics company focused on the treatment of rare and degenerative diseases within the Central Nervous System (CNS),.

United statesNew yorkTaejon gwangyoksiSouth koreaUnited kingdomBranden ryuNanomedicine btriScott powellRockefeller plazaSkyline corporate communications groupMerck advance biotech grant programCo ltdMerck groupBrain targeting ribonucleic acid interferenceCentral nervous systemAdvance biotech grant

BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program (BMD-001) and IV-Formulated siRNA Data at BIO2023 International Conference

/PRNewswire/ BIORCHESTRA, a biotherapeutics company focused on the treatment of rare and degenerative diseases within the Central Nervous System (CNS),.

United statesNew yorkTaejon gwangyoksiSouth koreaUnited kingdomNanomedicine btriRockefeller plazaScott powellBranden ryuSkyline corporate communications groupCo ltdInternational conventionBiotechnology innovation organization international conventionBusiness forumAchieving intravenousCentral nervous system

BIORCHESTRA Scientific Founder, Chairman, and Chief Executive Officer Joins the Republic of Korea (ROK) Official State Visit to the United States

The Official State visit by the President of the Republic of Korea marks the 70th anniversary of the U.S.-ROK alliance, which is advancing peace, stability,.

Taejon gwangyoksiSouth koreaUnited statesUnited kingdomNew yorkRepublic of koreaNanomedicine btriLady kim keon heeYoon suk yeolBranden ryuRockefeller plazaScott powellSkyline corporate communications groupCo ltdOfficial stateFirst lady kim keon hee

BIORCHESTRA Announces Significant Progress in Studies of BMD-001 Drug Program

Encouraging non-human primate (NHP) findings support the progression of IV-formulated BMD-001 ahead of formal clinical studies for Alzheimer s dis.

United kingdomUnited statesSouth koreaTaejon gwangyoksiNew yorkNanomedicine btriAkcea ionisScott powellBranden ryuRockefeller plazaSkyline corporate communications groupCo ltdAmyotrophic lateral sclerosisBrain targetingInvestigational new drugCentral nervous system

vimarsana © 2020. All Rights Reserved.